Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

Dec 2020| TBR1181B| TBRC (Publisher)

Report Highlights

Including: By Application: Oncology; Chronic and Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Covering: Teva Pharmaceutical Industries Ltd.; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories

Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the Filgrastim Biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Filgrastim Biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by game type, and by device.
  • Market Characteristics – The market characteristics section of the report defines and explains the filgrastim biosimilars market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global filgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the filgrastim biosimilars market.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global filgrastim biosimilars market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for filgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global filgrastim biosimilars market is segmented into –

By Application: Oncology; Chronic and Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Others
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

  • Table 1 : Global Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 2 : Global Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 3 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 4 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 5 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 6 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 7 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 8 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 9 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 10 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 11 : Asia Pacific Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 12 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 13 : Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 14 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 15 : Asia-Pacific Biologics Market Size, 2015-2019, $ Billion
  • Table 16 : Asia-Pacific Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 17 : Asia-Pacific Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 18 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 19 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 20 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 21 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 22 : China Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 23 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 24 : China Per Capita Net Disposable Income, 2015-2019, $
  • Table 25 : China Population By Age Group, 2015-2023, Thousands
  • Table 26 : China Biologics Market Size, 2015-2019, $ Billion
  • Table 27 : China Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 28 : China Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 29 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 30 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 31 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 32 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 33 : India Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 34 : India Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 35 : India Per Capita Net Disposable Income, 2015-2019, $
  • Table 36 : India Population By Age Group, 2015-2023, Thousands
  • Table 37 : India Biologics Market Size, 2015-2019, $ Billion
  • Table 38 : India Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 39 : India Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 40 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 41 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 42 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 43 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44 : Japan Cancer Prevalence, Estimated Average Expenditure, 2019, $
  • Table 45 : Japan Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 46 : Japan Per Capita Net Disposable Income, 2015-2019, $
  • Table 47 : Japan Population By Age Group, 2015-2023, Thousands
  • Table 48 : Japan Biologics Market Size, 2015-2019, $ Billion
  • Table 49 : Japan Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 50 : Japan Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 51 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 52 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 53 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 54 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 55 : Australia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 56 : Australia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 57 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 58 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 59 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 60 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 61 : Indonesia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 62 : Indonesia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 63 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 64 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 65 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 66 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 67 : South Korea Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 68 : South Korea Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 69 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 70 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 71 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 72 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 73 : Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
  • Table 74 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 75 : Western Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 76 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 77 : Western Europe Biologics Market Size, 2015-2019, $ Billion
  • Table 78 : Western Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 79 : Western Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 80 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 81 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 82 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 83 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 84 : UK Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 85 : UK Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 86 : UK Per Capita Net Disposable Income, 2015-2019, $
  • Table 87 : UK Population By Age Group, 2015-2023, Thousands
  • Table 88 : UK Biologics Market Size, 2015-2019, $ Billion
  • Table 89 : UK Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 90 : UK Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 91 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 92 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 93 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 94 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 95 : Germany Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 96 : Germany Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 97 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 98 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 99 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 100 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 101 : France Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 102 : France Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 103 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 104 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 105 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 106 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 107 : Eastern Europe Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 108 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 109 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 110 : Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 111 : Eastern Europe Biologics Market Size, 2015-2019, $ Billion
  • Table 112 : Eastern Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 113 : Eastern Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 114 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 115 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 116 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 117 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 118 : Russia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 119 : Russia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 120 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 121 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 122 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 123 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 124 : North America Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 125 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 126 : North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 127 : North America Population By Age Group, 2015-2023, Thousands
  • Table 128 : North America Biologics Market Size, 2015-2019, $ Billion
  • Table 129 : North America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 130 : North America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 131 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 132 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 133 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 134 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 135 : USA Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 136 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 137 : USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 138 : USA Market, Population By Age Group, 2015-2023, Thousands
  • Table 139 : USA Biologics Market Size, 2015-2019, $ Billion
  • Table 140 : USA Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 141 : USA Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 142 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 143 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 144 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 145 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 146 : South America Estimated Average Expenditure, Filgrastim Biosimilar Market, Cancer Prevalence, 2019
  • Table 147 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 148 : South America Population By Age Group, 2015-2023, Thousands
  • Table 149 : South America Per Capita Net Disposable Income, 2015-2019, $
  • Table 150 : South America Biologics Market Size, 2015-2019, $ Billion
  • Table 151 : South America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 152 : South America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 153 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 154 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 155 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 156 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 157 : Brazil Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 158 : Brazil Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 159 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 160 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 161 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 162 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 163 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 164 : Middle East Per Capita Net Disposable Income, 2015-2019, $
  • Table 165 : Middle East Population By Age Group, 2015-2023, Thousands
  • Table 166 : Middle East Biologics Market Size, 2015-2019, $ Billion
  • Table 167 : Middle East Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 168 : Middle East Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 169 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 170 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 171 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 172 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 173 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 174 : Africa Per Capita Net Disposable Income, 2015-2019, $
  • Table 175 : Africa Population By Age Group, 2015-2023, Thousands
  • Table 176 : Africa Biologics Market Size, 2015-2019, $ Billion
  • Table 177 : Africa Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Table 178 : Africa Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Table 179 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 180 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 181 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Table 182 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • Table 183 : Global Filgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 184 : Teva Pharmaceutical Industries Ltd.- Financial Performance, 2015 - 2019, $ Billion
  • Table 185 : Novartis International AG - Financial Performance, 2015 - 2019, $ Billion
  • Table 186 : Biocon Limited - Financial Performance, 2015 - 2019, $ Billion
  • Table 187 : Dr. Reddy's Laboratories - Financial Performance, 2015 - 2019, $ Billion
  • Table 188 : Global Filgrastim Biosimilars Market Size Gain ($ Million), 2019 - 2023, By Country
  • Table 189 : Global Filgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Application, 2019 - 2023
  • Table 190 : Global Filgrastim Biosimilars Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 - 2023
  • Table 191 : Filgrastim Biosimilars Market Data Sources
  • Figure 1 : Global Filgrastim Biosimilars Market Segmentation By Application
  • Figure 2 : Global Filgrastim Biosimilars Market Segmentation By Distribution Channel
  • Figure 3 : Global Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 4 : Global Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 5 : Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 6 : Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 7 : Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 8 : Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 9 : Asia-Pacific Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 10 : Asia-Pacific Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 11 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 12 : Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 13 : China Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 14 : China Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 15 : China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 16 : China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 17 : India Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 18 : India Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 19 : India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 20 : India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 21 : Japan Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 22 : Japan Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 23 : Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 24 : Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 25 : Australia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 26 : Australia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 27 : Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 28 : Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29 : Indonesia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 30 : Indonesia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 31 : Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 32 : Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 33 : South Korea Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 34 : South Korea Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 35 : South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 36 : South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 37 : Western Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 38 : Western Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 39 : Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 40 : Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 41 : UK Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 42 : UK Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 43 : UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 44 : UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 45 : Germany Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 46 : Germany Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 47 : Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 48 : Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 49 : France Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 50 : France Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 51 : France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 52 : France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 53 : Eastern Europe Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 54 : Eastern Europe Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 55 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 56 : Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 57 : Russia Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 58 : Russia Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 59 : Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 60 : Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 61 : North America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 62 : North America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 63 : North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 64 : North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 65 : USA Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 66 : USA Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 67 : USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 68 : USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 69 : South America Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 70 : South America Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 71 : South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 72 : South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 73 : Brazil Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 74 : Brazil Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 75 : Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 76 : Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 77 : Middle East Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 78 : Middle East Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 79 : Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 80 : Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 81 : Africa Filgrastim Biosimilars Market, Historic, 2015 - 2019, $ Million
  • Figure 82 : Africa Filgrastim Biosimilars Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million
  • Figure 83 : Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 84 : Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 85 : Global Filgrastim Biosimilars Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 86 : Teva Pharmaceutical Industries Ltd. - Financial Performance, 2015 - 2019, $ Billion
  • Figure 87 : Novartis International AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 88 : Biocon Limited - Financial Performance, 2015 - 2019, $ Billion
  • Figure 89 : Dr. Reddy's Laboratories - Financial Performance, 2015 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report